Related Experiment Video
Updated: Oct 15, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Combinatorial Analysis of Phenotypic and Clinical Risk Factors Associated With Hospitalized COVID-19 Patients
Sayoni Das1, Matthew Pearson1, Krystyna Taylor1
1PrecisionLife Ltd., Oxford, United Kingdom.
Insights
Severe COVID-19 risk factors were identified using clinical data. Lower lipid and calcium levels, along with leukocytes, were linked to increased hospitalization risk, suggesting shared biological pathways.
Area of Science:
- Infectious Diseases
- Biochemistry
- Medical Informatics
Background:
- Understanding risk factors for severe COVID-19 is crucial for patient outcomes.
- Previous genomic studies suggested a link between calcium/lipid homeostasis and severe COVID-19.
- Clinical and phenotypic data analysis is needed to validate these findings in diverse populations.
Purpose of the Study:
- To identify clinical and phenotypic disease signatures associated with severe COVID-19 hospitalization.
- To analyze combinations of features in a separate patient cohort using clinical data.
- To explore potential shared mechanisms between calcium, lipid, and immune cell signaling in severe COVID-19.
Main Methods:
- Utilized the PrecisionLife combinatorial analytics platform on de-identified health records from the UnitedHealth Group COVID-19 Data Suite.
- Analyzed 836 disease signatures across two cohorts: hospitalized COVID-19 cases vs. mild cases, and a subset with laboratory data.
- Investigated associations between lipid levels, serum calcium, leukocytes, statin use, and vitamin D deficiency.
Main Results:
- Identified multiple disease signatures correlating with increased COVID-19 hospitalization risk.
- Found co-occurrence of lower lipid levels with lower serum calcium and leukocytes in severe cases.
- Observed that hypocalcemia signatures were frequently linked to vitamin D deficiency and often independent of statin use.
Conclusions:
- Combinatorial analysis of clinical data can identify severe COVID-19 risk signatures independently of genomic data.
- Findings support a potential role for calcium and lipid signaling pathways in the pathophysiology of severe COVID-19.
- The identified signatures offer insights into host-pathogen interactions and potential therapeutic targets.
Abstract:
Characterization of the risk factors associated with variability in the clinical outcomes of COVID-19 is important. Our previous study using genomic data identified a potential role of calcium and lipid homeostasis in severe COVID-19. This study aimed to identify similar combinations of features (disease signatures) associated with severe disease in a separate patient population with purely clinical and phenotypic data. The PrecisionLife combinatorial analytics platform was used to analyze features derived from de-identified health records in the UnitedHealth Group COVID-19 Data Suite. The platform identified and analyzed 836 disease signatures in two cohorts associated with an increased risk of COVID-19 hospitalization. Cohort 1 was formed of cases hospitalized with COVID-19 and a set of controls who developed mild symptoms. Cohort 2 included Cohort 1 individuals for whom additional laboratory test data was available. We found several disease signatures where lower levels of lipids were found co-occurring with lower levels of serum calcium and leukocytes. Many of the low lipid signatures were independent of statin use and 50% of cases with hypocalcemia signatures were reported with vitamin D deficiency. These signatures may be attributed to similar mechanisms linking calcium and lipid signaling where changes in cellular lipid levels during inflammation and infection affect calcium signaling in host cells. This study and our previous genomics analysis demonstrate that combinatorial analysis can identify disease signatures associated with the risk of developing severe COVID-19 separately from genomic or clinical data in different populations. Both studies suggest associations between calcium and lipid signaling in severe COVID-19.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Single Nucleotide Polymorphisms-SNPs
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Contingency Table
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

